SARS-CoV-2
Showing NaN - NaN of 8
Asymptomatic SARS-CoV-2 Detection in Children
Completed
- Covid19
- SARS-CoV-2
-
Birmingham, Alabama
- +4 more
Nov 1, 2022
SARS-CoV-2 Trial in United States (CV2CoV (2 µg), CV2CoV (4 µg), CV2CoV (8 µg))
Recruiting
- SARS-CoV-2
- CV2CoV (2 µg)
- +5 more
-
La Mesa, California
- +13 more
Jul 21, 2022
COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- Placebo
-
Phoenix, Arizona
- +83 more
Jul 13, 2022
COVID-19, SARS-CoV-2 Trial in Puerto Rico, United States (Abatacept, Placebo)
Terminated
- COVID-19
- SARS-CoV-2
- Abatacept
- Placebo
-
Hialeah, Florida
- +9 more
Jul 6, 2022
COVID, COVID-19, SARS-CoV-2 Trial in Worldwide (biological, other, drug)
Completed
- COVID
- +3 more
- Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
- +2 more
-
Colorado Springs, Colorado
- +38 more
Mar 31, 2022
COVID-19: Human Epidemiology and Response to SARS-CoV-2
Completed
- Coronavirus Disease 2019 (COVID-19)
- SARS-CoV-2
- Collection of Biological Samples
- Symptom and Exposure Surveys
-
Aurora, Colorado
- +19 more
Feb 11, 2021